by David Rosenbaum | Mar 17, 2020 | Uncategorized
Disasters and protests tend to bring out opportunists who attempt to capitalize on a popular term or rallying cry. This often ends in trademark applicants burning money on trademark applications that will likely end in both rejection by the United States Patent and...
by David Rosenbaum | Jan 15, 2020 | Uncategorized
By James Heracklis Blockchain Patentability Background Since blockchain technology was created in 2008 by the founder of Bitcoin, Satoshi Nakamoto, it has been difficult for the patent community to understand how to best handle blockchain innovations. The algorithms...
by David Rosenbaum | Aug 5, 2019 | Uncategorized
By: Adam Baechler Effective August 3, 2019, the United States Patent and Trademark Office (USPTO) enacted a new rule requiring all foreign trademark applicants and registrants be represented by a U.S. licensed attorney.[1] Foreign trademark applicants and registrants...
by David Rosenbaum | Sep 2, 2017 | FDA, Medical Devices
Congratulations to our client BiO2 Medical, Inc.!!! In a paper published in the last week, two officials from the US Food and Drug Administration (FDA) say that the agency’s early feasibility study (EFS) program helped optimize the development of a new type of...
